Imidazo[1,2-B][1,2,4]triazines as C-MET inhibitors
申请人:Zhuo Jincong
公开号:US08487096B2
公开(公告)日:2013-07-16
The present invention relates to imidazo[1,2-b][1,2,4]triazines that are inhibitors of c-Met and are useful in the treatment of c-Met associated diseases including cancer.
Imidazo[1,2-B][1,2,4]triazines as c-Met inhibitors
申请人:Incyte Corporation
公开号:US09221824B2
公开(公告)日:2015-12-29
The present invention relates to imidazo[1,2-b][1,2,4]triazines that are inhibitors of c-Met and are useful in the treatment of c-Met associated diseases including cancer.